{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:21:40Z","timestamp":1793388100347,"version":"4.5.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["Grant Nos. 82271199"],"award-info":[{"award-number":["Grant Nos. 82271199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["82471421"],"award-info":[{"award-number":["82471421"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["92268118"],"award-info":[{"award-number":["92268118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific research project of the Institute of Basic Science of Shaanxi Provincial Department of Education","award":["Grant Nos. 23JHQ057"],"award-info":[{"award-number":["Grant Nos. 23JHQ057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00415-025-13101-4","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:09:56Z","timestamp":1745867396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Advances in research on mitochondrial dysfunction in neurodegenerative diseases"],"prefix":"10.1007","volume":"272","author":[{"given":"Yao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8254-3329","authenticated-orcid":false,"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"issue":"7","key":"13101_CR1","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1083\/jcb.201803152","volume":"217","author":"G Yellen","year":"2018","unstructured":"Yellen G (2018) Fueling thought: management of glycolysis and oxidative phosphorylation in neuronal metabolism. J Cell Biol 217(7):2235\u20132246","journal-title":"J Cell Biol"},{"key":"13101_CR2","doi-asserted-by":"publisher","first-page":"2874283","DOI":"10.1155\/2017\/2874283","volume":"2017","author":"JG Lees","year":"2017","unstructured":"Lees JG, Gardner DK, Harvey AJ (2017) Pluripotent stem cell metabolism and mitochondria: beyond ATP. Stem Cells Int 2017:2874283","journal-title":"Stem Cells Int"},{"issue":"1","key":"13101_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12974-019-1659-1","volume":"16","author":"D Tu","year":"2019","unstructured":"Tu D et al (2019) The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration. J Neuroinflammation 16(1):255","journal-title":"J Neuroinflammation"},{"issue":"4","key":"13101_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","volume":"21","author":"M Giacomello","year":"2020","unstructured":"Giacomello M et al (2020) The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol 21(4):204\u2013224","journal-title":"Nat Rev Mol Cell Biol"},{"key":"13101_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jprot.2015.03.005","volume":"120","author":"K V\u00f6lgyi","year":"2015","unstructured":"V\u00f6lgyi K et al (2015) Synaptic mitochondria: a brain mitochondria cluster with a specific proteome. J Proteomics 120:142\u2013157","journal-title":"J Proteomics"},{"key":"13101_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101039","volume":"59","author":"JL Gollihue","year":"2020","unstructured":"Gollihue JL, Norris CM (2020) Astrocyte mitochondria: Central players and potential therapeutic targets for neurodegenerative diseases and injury. Ageing Res Rev 59:101039","journal-title":"Ageing Res Rev"},{"issue":"1","key":"13101_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1515\/hsz-2020-0231","volume":"402","author":"S Wanderoy","year":"2020","unstructured":"Wanderoy S et al (2020) Kill one or kill the many: interplay between mitophagy and apoptosis. Biol Chem 402(1):73\u201388","journal-title":"Biol Chem"},{"issue":"19","key":"13101_CR8","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ et al (2021) Autophagy in major human diseases. Embo j 40(19):e108863","journal-title":"Embo j"},{"issue":"1","key":"13101_CR9","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1038\/s41467-021-26746-2","volume":"12","author":"CY Chung","year":"2021","unstructured":"Chung CY et al (2021) Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation. Nat Commun. 12(1):6409","journal-title":"Nat Commun."},{"issue":"3","key":"13101_CR10","first-page":"antiox13030312","volume":"13","author":"Y Hong","year":"2024","unstructured":"Hong Y et al (2024) Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution. Antioxidants (Basel) 13(3):antiox13030312","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"13101_CR11","first-page":"185","volume":"13","author":"A Afsar","year":"2024","unstructured":"Afsar A, Zhang L (2024) Putative molecular mechanisms underpinning the inverse roles of mitochondrial respiration and heme function in lung cancer and Alzheimer\u2019s disease. Biology (Basel) 13(3):185","journal-title":"Biology (Basel)"},{"issue":"24","key":"13101_CR12","doi-asserted-by":"publisher","first-page":"ijms232416053","DOI":"10.3390\/ijms232416053","volume":"23","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) Mitochondrial dysfunction and therapeutic perspectives in cardiovascular diseases. Int J Mol Sci 23(24):ijms232416053","journal-title":"Int J Mol Sci"},{"key":"13101_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149799","volume":"708","author":"J Wu","year":"2024","unstructured":"Wu J et al (2024) Calcium-induced upregulation of energy metabolism heats neurons during neural activity. Biochem Biophys Res Commun 708:149799","journal-title":"Biochem Biophys Res Commun"},{"key":"13101_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fncel.2020.00071","volume":"14","author":"S Xapelli","year":"2020","unstructured":"Xapelli S et al (2020) Editorial: glial and neural stem cells as new therapeutic targets for neurodegenerative disorders. Front Cell Neurosci 14:71","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"13101_CR15","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1093\/molbev\/msx197","volume":"34","author":"R Allio","year":"2017","unstructured":"Allio R et al (2017) Large variation in the ratio of mitochondrial to nuclear mutation rate across animals: implications for genetic diversity and the use of mitochondrial DNA as a molecular marker. Mol Biol Evol 34(11):2762\u20132772","journal-title":"Mol Biol Evol"},{"issue":"3","key":"13101_CR16","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3233\/JAD-230880","volume":"97","author":"IK Gorham","year":"2024","unstructured":"Gorham IK et al (2024) Blood-based mtDNA quantification indicates population-specific differences associated with Alzheimer\u2019s disease-related risk. J Alzheimers Dis 97(3):1407\u20131419","journal-title":"J Alzheimers Dis"},{"key":"13101_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.654785","volume":"15","author":"D Yang","year":"2021","unstructured":"Yang D et al (2021) Mitochondrial dynamics: a key role in neurodegeneration and a potential target for neurodegenerative disease. Front Neurosci 15:654785","journal-title":"Front Neurosci"},{"key":"13101_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.617588","volume":"13","author":"A Misrani","year":"2021","unstructured":"Misrani A, Tabassum S, Yang L (2021) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease. Front Aging Neurosci 13:617588","journal-title":"Front Aging Neurosci"},{"key":"13101_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-016-0065-1","volume":"5","author":"B Wang","year":"2016","unstructured":"Wang B et al (2016) Dysregulation of autophagy and mitochondrial function in Parkinson\u2019s disease. Transl Neurodegener 5:19","journal-title":"Transl Neurodegener"},{"issue":"19","key":"13101_CR20","doi-asserted-by":"publisher","first-page":"11391","DOI":"10.3390\/ijms231911391","volume":"23","author":"V Bazzani","year":"2022","unstructured":"Bazzani V et al (2022) Mitochondrial DNA repair in neurodegenerative diseases and ageing. Int J Mol Sci 23(19):11391","journal-title":"Int J Mol Sci"},{"issue":"5","key":"13101_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/antiox11050801","volume":"11","author":"D Matuz-Mares","year":"2022","unstructured":"Matuz-Mares D et al (2022) Mitochondrial calcium: effects of its imbalance in disease. Antioxidants (Basel) 11(5):801","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"13101_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E (2016) The cellular phase of Alzheimer\u2019s disease. Cell 164(4):603\u2013615","journal-title":"Cell"},{"key":"13101_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101307","volume":"67","author":"A Kobro-Flatmoen","year":"2021","unstructured":"Kobro-Flatmoen A et al (2021) Re-emphasizing early Alzheimer\u2019s disease pathology starting in select entorhinal neurons, with a special focus on mitophagy. Ageing Res Rev 67:101307","journal-title":"Ageing Res Rev"},{"issue":"1","key":"13101_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","volume":"141","author":"L Vaillant-Beuchot","year":"2021","unstructured":"Vaillant-Beuchot L et al (2021) Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains. Acta Neuropathol 141(1):39\u201365","journal-title":"Acta Neuropathol"},{"issue":"11","key":"13101_CR25","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","volume":"18","author":"S Khan","year":"2020","unstructured":"Khan S, Barve KH, Kumar MS (2020) Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s disease. Curr Neuropharmacol 18(11):1106\u20131125","journal-title":"Curr Neuropharmacol"},{"key":"13101_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3389\/fphar.2020.00709","volume":"11","author":"JD Panes","year":"2020","unstructured":"Panes JD et al (2020) Changes in PGC-1\u03b1\/SIRT1 signaling impact on mitochondrial homeostasis in amyloid-beta peptide toxicity model. Front Pharmacol 11:709","journal-title":"Front Pharmacol"},{"key":"13101_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-neuro-080317-061725","volume":"41","author":"B Zott","year":"2018","unstructured":"Zott B et al (2018) What happens with the circuit in Alzheimer\u2019s disease in mice and humans? Annu Rev Neurosci 41:277\u2013297","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"13101_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/antiox10010061","volume":"10","author":"PJ Urrutia","year":"2021","unstructured":"Urrutia PJ, B\u00f3rquez DA, N\u00fa\u00f1ez MT (2021) Inflaming the brain with iron. Antioxidants (Basel) 10(1):61","journal-title":"Antioxidants (Basel)"},{"issue":"10","key":"13101_CR29","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.cmet.2021.06.013","volume":"33","author":"S Liu","year":"2021","unstructured":"Liu S et al (2021) Glycerol-3-phosphate biosynthesis regenerates cytosolic NAD(+) to alleviate mitochondrial disease. Cell Metab 33(10):1974-1987.e9","journal-title":"Cell Metab"},{"issue":"1","key":"13101_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12974-022-02613-9","volume":"19","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer\u2019s disease. J Neuroinflammation 19(1):248","journal-title":"J Neuroinflammation"},{"issue":"1","key":"13101_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40478-021-01126-5","volume":"9","author":"B Kenkhuis","year":"2021","unstructured":"Kenkhuis B et al (2021) Iron loading is a prominent feature of activated microglia in Alzheimer\u2019s disease patients. Acta Neuropathol Commun 9(1):27","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"13101_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF et al (2019) Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci 22(3):401\u2013412","journal-title":"Nat Neurosci"},{"issue":"1","key":"13101_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41380-022-01631-6","volume":"28","author":"A Mary","year":"2023","unstructured":"Mary A et al (2023) Mitophagy in Alzheimer\u2019s disease: molecular defects and therapeutic approaches. Mol Psychiatry 28(1):202\u2013216","journal-title":"Mol Psychiatry"},{"key":"13101_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.freeradbiomed.2021.07.013","volume":"172","author":"H Morton","year":"2021","unstructured":"Morton H et al (2021) Defective mitophagy and synaptic degeneration in Alzheimer\u2019s disease: focus on aging, mitochondria and synapse. Free Radic Biol Med 172:652\u2013667","journal-title":"Free Radic Biol Med"},{"key":"13101_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112918","volume":"149","author":"JA Pradeepkiran","year":"2022","unstructured":"Pradeepkiran JA et al (2022) Are mitophagy enhancers therapeutic targets for Alzheimer\u2019s disease? Biomed Pharmacother 149:112918","journal-title":"Biomed Pharmacother"},{"key":"13101_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fncel.2016.00024","volume":"10","author":"Q Cai","year":"2016","unstructured":"Cai Q, Tammineni P (2016) Alterations in mitochondrial quality control in Alzheimer\u2019s disease. Front Cell Neurosci 10:24","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"13101_CR37","doi-asserted-by":"publisher","first-page":"8429","DOI":"10.1002\/alz.14275","volume":"20","author":"AP Gabrielli","year":"2024","unstructured":"Gabrielli AP et al (2024) Inhibiting mtDNA transcript translation alters Alzheimer\u2019s disease-associated biology. Alzheimers Dement 20(12):8429\u20138443","journal-title":"Alzheimers Dement"},{"key":"13101_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neurobiolaging.2018.09.015","volume":"73","author":"DT Soltys","year":"2019","unstructured":"Soltys DT et al (2019) Lower mitochondrial DNA content but not increased mutagenesis associates with decreased base excision repair activity in brains of AD subjects. Neurobiol Aging 73:161\u2013170","journal-title":"Neurobiol Aging"},{"issue":"2","key":"13101_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ana.24709","volume":"80","author":"JG Hoekstra","year":"2016","unstructured":"Hoekstra JG et al (2016) Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage. Ann Neurol 80(2):301\u2013306","journal-title":"Ann Neurol"},{"issue":"10291","key":"13101_CR40","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303","journal-title":"Lancet"},{"key":"13101_CR41","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013","journal-title":"Nat Rev Dis Primers"},{"key":"13101_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","volume":"42","author":"H Deng","year":"2018","unstructured":"Deng H, Wang P, Jankovic J (2018) The genetics of Parkinson disease. Ageing Res Rev 42:72\u201385","journal-title":"Ageing Res Rev"},{"key":"13101_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","volume":"177","author":"A Gr\u00fcnewald","year":"2019","unstructured":"Gr\u00fcnewald A, Kumar KR, Sue CM (2019) New insights into the complex role of mitochondria in Parkinson\u2019s disease. Prog Neurobiol 177:73\u201393","journal-title":"Prog Neurobiol"},{"issue":"6","key":"13101_CR44","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39(6):889\u2013909","journal-title":"Neuron"},{"issue":"7886","key":"13101_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez P et al (2021) Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 599(7886):650\u2013656","journal-title":"Nature"},{"key":"13101_CR46","doi-asserted-by":"publisher","first-page":"13548","DOI":"10.1038\/ncomms13548","volume":"7","author":"C D\u00f6lle","year":"2016","unstructured":"D\u00f6lle C et al (2016) Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. Nat Commun 7:13548","journal-title":"Nat Commun"},{"issue":"13","key":"13101_CR47","doi-asserted-by":"publisher","first-page":"ijms22137030","DOI":"10.3390\/ijms22137030","volume":"22","author":"GE Moya","year":"2021","unstructured":"Moya GE, Rivera PD, Dittenhafer-Reed KE (2021) Evidence for the role of mitochondrial DNA release in the inflammatory response in neurological disorders. Int J Mol Sci 22(13):ijms22137030","journal-title":"Int J Mol Sci"},{"issue":"1","key":"13101_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","volume":"15","author":"P Ge","year":"2020","unstructured":"Ge P, Dawson VL, Dawson TM (2020) PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease. Mol Neurodegener 15(1):20","journal-title":"Mol Neurodegener"},{"issue":"5","key":"13101_CR49","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00401-021-02285-4","volume":"141","author":"JM Tokarew","year":"2021","unstructured":"Tokarew JM et al (2021) Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites. Acta Neuropathol 141(5):725\u2013754","journal-title":"Acta Neuropathol"},{"issue":"15","key":"13101_CR50","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"N Panicker","year":"2022","unstructured":"Panicker N et al (2022) Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron 110(15):2422-2437.e9","journal-title":"Neuron"},{"issue":"6","key":"13101_CR51","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1172\/JCI95898","volume":"128","author":"JN Guzman","year":"2018","unstructured":"Guzman JN et al (2018) Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress. J Clin Invest 128(6):2266\u20132280","journal-title":"J Clin Invest"},{"issue":"4","key":"13101_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB et al (2021) Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci 46(4):329\u2013343","journal-title":"Trends Biochem Sci"},{"issue":"6357","key":"13101_CR53","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF et al (2017) Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357(6357):1255\u20131261","journal-title":"Science"},{"issue":"7548","key":"13101_CR54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP et al (2015) Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520(7548):553\u2013557","journal-title":"Nature"},{"issue":"3","key":"13101_CR55","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2174\/1570159X20666220810114644","volume":"21","author":"D Shang","year":"2023","unstructured":"Shang D et al (2023) mtDNA maintenance and Alterations in the pathogenesis of neurodegenerative diseases. Curr Neuropharmacol 21(3):578\u2013598","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"13101_CR56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334","journal-title":"Eur J Neurol"},{"issue":"5","key":"13101_CR57","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S (2016) The biology of Huntingtin. Neuron 89(5):910\u2013926","journal-title":"Neuron"},{"issue":"7","key":"13101_CR58","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.4103\/1673-5374.360289","volume":"18","author":"A Jurcau","year":"2023","unstructured":"Jurcau A, Jurcau CM (2023) Mitochondria in Huntington\u2019s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies. Neural Regen Res 18(7):1472\u20131477","journal-title":"Neural Regen Res"},{"issue":"12","key":"13101_CR59","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1007\/s12035-021-02556-x","volume":"58","author":"N Sawant","year":"2021","unstructured":"Sawant N et al (2021) Mitochondrial abnormalities and synaptic damage in Huntington\u2019s disease: a focus on defective mitophagy and mitochondria-targeted therapeutics. Mol Neurobiol 58(12):6350\u20136377","journal-title":"Mol Neurobiol"},{"issue":"7","key":"13101_CR60","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.freeradbiomed.2012.06.008","volume":"53","author":"A Siddiqui","year":"2012","unstructured":"Siddiqui A et al (2012) Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington\u2019s disease. Free Radic Biol Med 53(7):1478\u20131488","journal-title":"Free Radic Biol Med"},{"key":"13101_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnmol.2019.00068","volume":"12","author":"BD Paul","year":"2019","unstructured":"Paul BD, Snyder SH (2019) Impaired redox signaling in Huntington\u2019s disease: therapeutic implications. Front Mol Neurosci 12:68","journal-title":"Front Mol Neurosci"},{"key":"13101_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106667","volume":"201","author":"S Gharaba","year":"2024","unstructured":"Gharaba S et al (2024) Characterization of fission and fusion mitochondrial dynamics in HD fibroblasts according to patient\u2019s severity status. Neurobiol Dis 201:106667","journal-title":"Neurobiol Dis"},{"issue":"4","key":"13101_CR63","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s43440-024-00619-z","volume":"76","author":"S Upadhayay","year":"2024","unstructured":"Upadhayay S, Kumar P (2024) Mitochondrial targeted antioxidants as potential therapy for huntington\u2019s disease. Pharmacol Rep 76(4):693\u2013713","journal-title":"Pharmacol Rep"},{"issue":"7","key":"13101_CR64","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10571-007-9206-5","volume":"27","author":"MM Banoei","year":"2007","unstructured":"Banoei MM et al (2007) Huntington\u2019s disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?! Cell Mol Neurobiol 27(7):867\u2013875","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"13101_CR65","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/brain\/awae007","volume":"147","author":"A Neueder","year":"2024","unstructured":"Neueder A et al (2024) Huntington\u2019s disease affects mitochondrial network dynamics predisposing to pathogenic mitochondrial DNA mutations. Brain 147(6):2009\u20132022","journal-title":"Brain"},{"key":"13101_CR66","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnmol.2018.00329","volume":"11","author":"J Zheng","year":"2018","unstructured":"Zheng J et al (2018) A mitochondria-associated oxidative stress perspective on Huntington\u2019s disease. Front Mol Neurosci 11:329","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"13101_CR67","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/jnc.12190","volume":"125","author":"J Jin","year":"2013","unstructured":"Jin J et al (2013) Neuroprotective effects of PPAR-\u03b3 agonist rosiglitazone in N171\u201382Q mouse model of Huntington\u2019s disease. J Neurochem 125(3):410\u2013419","journal-title":"J Neurochem"},{"issue":"20","key":"13101_CR68","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1001\/jama.2022.14236","volume":"328","author":"R Marcus","year":"2022","unstructured":"Marcus R (2022) What is multiple sclerosis? JAMA 328(20):2078","journal-title":"JAMA"},{"issue":"7","key":"13101_CR69","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/1873-3468.13013","volume":"592","author":"G Campbell","year":"2018","unstructured":"Campbell G, Mahad DJ (2018) Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis. FEBS Lett 592(7):1113\u20131121","journal-title":"FEBS Lett"},{"issue":"9","key":"13101_CR70","first-page":"21","volume":"10","author":"M Yang","year":"2022","unstructured":"Yang M, Liu S, Zhang C (2022) The related metabolic diseases and treatments of obesity. Healthcare (Basel) 10(9):21","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"13101_CR71","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.22109","volume":"69","author":"GR Campbell","year":"2011","unstructured":"Campbell GR et al (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69(3):481\u2013492","journal-title":"Ann Neurol"},{"key":"13101_CR72","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61798","volume":"10","author":"SC Rosenkranz","year":"2021","unstructured":"Rosenkranz SC et al (2021) Enhancing mitochondrial activity in neurons protects against neurodegeneration in a mouse model of multiple sclerosis. Elife 10:e61798","journal-title":"Elife"},{"issue":"2","key":"13101_CR73","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00401-020-02179-x","volume":"140","author":"S Licht-Mayer","year":"2020","unstructured":"Licht-Mayer S et al (2020) Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis. Acta Neuropathol 140(2):143\u2013167","journal-title":"Acta Neuropathol"},{"issue":"8","key":"13101_CR74","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s42255-023-00838-3","volume":"5","author":"YH Tai","year":"2023","unstructured":"Tai YH et al (2023) Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesions. Nat Metab 5(8):1364\u20131381","journal-title":"Nat Metab"},{"issue":"4","key":"13101_CR75","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13760-016-0675-5","volume":"116","author":"S Andalib","year":"2016","unstructured":"Andalib S et al (2016) MtDNA T4216C variation in multiple sclerosis: a systematic review and meta-analysis. Acta Neurol Belg 116(4):439\u2013443","journal-title":"Acta Neurol Belg"},{"issue":"4","key":"13101_CR76","first-page":"203","volume":"20","author":"I Fyfe","year":"2024","unstructured":"Fyfe I (2024) Mitochondrial DNA marks multiple sclerosis. Nat Rev Neurol 20(4):203","journal-title":"Nat Rev Neurol"},{"key":"13101_CR77","doi-asserted-by":"crossref","unstructured":"Huang S, et al. (2024) Advanced sequencing-based high-throughput and long-read single-cell transcriptome analysis. Lab Chip. pp 2601\u20132621.","DOI":"10.1039\/D4LC00105B"},{"key":"13101_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.884748","volume":"10","author":"R Cuevas-Diaz Duran","year":"2022","unstructured":"Cuevas-Diaz Duran R et al (2022) Single-cell and single-nuclei RNA sequencing as powerful tools to decipher cellular heterogeneity and dysregulation in neurodegenerative diseases. Front Cell Dev Biol 10:884748","journal-title":"Front Cell Dev Biol"},{"issue":"9\u201310","key":"13101_CR79","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s10495-023-01865-x","volume":"28","author":"B Chen","year":"2023","unstructured":"Chen B et al (2023) Comprehensive analysis of mitochondrial dysfunction and necroptosis in intracranial aneurysms from the perspective of predictive, preventative, and personalized medicine. Apoptosis 28(9\u201310):1452\u20131468","journal-title":"Apoptosis"},{"issue":"3","key":"13101_CR80","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41591-021-01232-w","volume":"27","author":"YC Cohen","year":"2021","unstructured":"Cohen YC et al (2021) Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing. Nat Med 27(3):491\u2013503","journal-title":"Nat Med"},{"issue":"4","key":"13101_CR81","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00018-022-04201-9","volume":"79","author":"MR Aghanoori","year":"2022","unstructured":"Aghanoori MR et al (2022) CEBP\u03b2 regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth. Cell Mol Life Sci 79(4):193","journal-title":"Cell Mol Life Sci"},{"issue":"8006","key":"13101_CR82","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-024-07167-9","volume":"628","author":"L Peruzzotti-Jametti","year":"2024","unstructured":"Peruzzotti-Jametti L et al (2024) Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature 628(8006):195\u2013203","journal-title":"Nature"},{"issue":"7794","key":"13101_CR83","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/d41586-020-00341-9","volume":"578","author":"E Callaway","year":"2020","unstructured":"Callaway E (2020) Revolutionary cryo-EM is taking over structural biology. Nature 578(7794):201","journal-title":"Nature"},{"issue":"7832","key":"13101_CR84","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41586-020-2829-0","volume":"587","author":"T Nakane","year":"2020","unstructured":"Nakane T et al (2020) Single-particle cryo-EM at atomic resolution. Nature 587(7832):152\u2013156","journal-title":"Nature"},{"issue":"12","key":"13101_CR85","doi-asserted-by":"publisher","first-page":"eaax9484","DOI":"10.1126\/sciadv.aax9484","volume":"5","author":"K Parey","year":"2019","unstructured":"Parey K et al (2019) High-resolution cryo-EM structures of respiratory complex I: mechanism, assembly, and disease. Sci Adv 5(12):eaax9484","journal-title":"Sci Adv"},{"issue":"1","key":"13101_CR86","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41467-024-45524-4","volume":"15","author":"K Rochon","year":"2024","unstructured":"Rochon K et al (2024) Structural basis for regulated assembly of the mitochondrial fission GTPase Drp1. Nat Commun 15(1):1328","journal-title":"Nat Commun"},{"key":"13101_CR87","doi-asserted-by":"publisher","DOI":"10.1017\/S0033583521000020","volume":"54","author":"E D'Imprima","year":"2021","unstructured":"D\u2019Imprima E, K\u00fchlbrandt W (2021) Current limitations to high-resolution structure determination by single-particle cryoEM. Q Rev Biophys 54:e4","journal-title":"Q Rev Biophys"},{"key":"13101_CR88","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.tice.2018.08.011","volume":"57","author":"D Smith","year":"2019","unstructured":"Smith D, Starborg T (2019) Serial block face scanning electron microscopy in cell biology: applications and technology. Tissue Cell 57:111\u2013122","journal-title":"Tissue Cell"},{"issue":"6","key":"13101_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109509","volume":"36","author":"J Faitg","year":"2021","unstructured":"Faitg J et al (2021) 3D neuronal mitochondrial morphology in axons, dendrites, and somata of the aging mouse hippocampus. Cell Rep 36(6):109509","journal-title":"Cell Rep"},{"issue":"11","key":"13101_CR90","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41596-022-00719-1","volume":"17","author":"P D'Acunzo","year":"2022","unstructured":"D\u2019Acunzo P et al (2022) Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues. Nat Protoc 17(11):2517\u20132549","journal-title":"Nat Protoc"},{"key":"13101_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102264","volume":"213","author":"S Aten","year":"2022","unstructured":"Aten S et al (2022) Ultrastructural view of astrocyte arborization, astrocyte-astrocyte and astrocyte-synapse contacts, intracellular vesicle-like structures, and mitochondrial network. Prog Neurobiol 213:102264","journal-title":"Prog Neurobiol"},{"issue":"3","key":"13101_CR92","doi-asserted-by":"publisher","first-page":"ENEURO.0241-23.","DOI":"10.1523\/ENEURO.0241-23.2024","volume":"11","author":"GJ Masilamoni","year":"2024","unstructured":"Masilamoni GJ et al (2024) Structural plasticity of GABAergic pallidothalamic terminals in MPTP-treated Parkinsonian monkeys: a 3D electron microscopic analysis. eNeuro. 11(3):ENEURO.0241-23.2024","journal-title":"eNeuro."},{"issue":"3","key":"13101_CR93","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2024.01.005","volume":"187","author":"CL McCafferty","year":"2024","unstructured":"McCafferty CL et al (2024) Integrating cellular electron microscopy with multimodal data to explore biology across space and time. Cell 187(3):563\u2013584","journal-title":"Cell"},{"key":"13101_CR94","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-biophys-111622-091212","volume":"52","author":"S Hugelier","year":"2023","unstructured":"Hugelier S, Colosi PL, Lakadamyali M (2023) Quantitative single-molecule localization microscopy. Annu Rev Biophys 52:139\u2013160","journal-title":"Annu Rev Biophys"},{"key":"13101_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105420","volume":"156","author":"S Calovi","year":"2021","unstructured":"Calovi S, Soria FN, T\u00f8nnesen J (2021) Super-resolution STED microscopy in live brain tissue. Neurobiol Dis 156:105420","journal-title":"Neurobiol Dis"},{"issue":"11","key":"13101_CR96","doi-asserted-by":"publisher","first-page":"E2634","DOI":"10.1073\/pnas.1713849115","volume":"115","author":"D Grassi","year":"2018","unstructured":"Grassi D et al (2018) Identification of a highly neurotoxic \u03b1-synuclein species inducing mitochondrial damage and mitophagy in Parkinson\u2019s disease. Proc Natl Acad Sci U S A 115(11):E2634-e2643","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"13101_CR97","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/s41467-020-17546-1","volume":"11","author":"X Yang","year":"2020","unstructured":"Yang X et al (2020) Mitochondrial dynamics quantitatively revealed by STED nanoscopy with an enhanced squaraine variant probe. Nat Commun 11(1):3699","journal-title":"Nat Commun"},{"issue":"3","key":"13101_CR98","doi-asserted-by":"publisher","first-page":"425","DOI":"10.14283\/jpad.2022.38","volume":"9","author":"A Ruiz","year":"2022","unstructured":"Ruiz A et al (2022) Evaluation of the feasibility, safety and efficacy of the use of intravenous infusions of Adenosine Triphosphate (ATP) in people affected by moderate to severe Alzheimer\u2019s disease: a double-blind masked clinical trial for dose finding. J Prev Alzheimers Dis 9(3):425\u2013434","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"13101_CR99","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/jcph.1008","volume":"58","author":"LD Coles","year":"2018","unstructured":"Coles LD et al (2018) Repeated-dose oral N-acetylcysteine in Parkinson\u2019s disease: pharmacokinetics and effect on brain glutathione and oxidative stress. J Clin Pharmacol 58(2):158\u2013167","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"13101_CR100","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/jmri.29017","volume":"59","author":"NA John","year":"2024","unstructured":"John NA et al (2024) Longitudinal metabolite changes in progressive multiple sclerosis: a study of 3 potential neuroprotective treatments. J Magn Reson Imaging 59(6):2192\u20132201","journal-title":"J Magn Reson Imaging"},{"issue":"9","key":"13101_CR101","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cmet.2024.05.016","volume":"36","author":"J Zhou","year":"2024","unstructured":"Zhou J et al (2024) Astrocytic LRP1 enables mitochondria transfer to neurons and mitigates brain ischemic stroke by suppressing ARF1 lactylation. Cell Metab 36(9):2054-2068.e14","journal-title":"Cell Metab"},{"issue":"1","key":"13101_CR102","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-023-00336-2","volume":"12","author":"B Yulug","year":"2023","unstructured":"Yulug B et al (2023) Combined metabolic activators improve cognitive functions in Alzheimer\u2019s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. Transl Neurodegener 12(1):4","journal-title":"Transl Neurodegener"},{"issue":"31","key":"13101_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304687","volume":"11","author":"X Zhong","year":"2024","unstructured":"Zhong X et al (2024) Cordycepin modulates microglial M2 polarization coupled with mitochondrial metabolic reprogramming by targeting HKII and PDK2. Adv Sci (Weinh) 11(31):e2304687","journal-title":"Adv Sci (Weinh)"},{"issue":"41","key":"13101_CR104","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.2174\/0929867325666180221125759","volume":"25","author":"C Tonda-Turo","year":"2018","unstructured":"Tonda-Turo C et al (2018) Current limitations in the treatment of Parkinson\u2019s and Alzheimer\u2019s diseases: state-of-the-art and future perspective of polymeric carriers. Curr Med Chem 25(41):5755\u20135771","journal-title":"Curr Med Chem"},{"issue":"7","key":"13101_CR105","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41422-024-00971-y","volume":"34","author":"TY Park","year":"2024","unstructured":"Park TY et al (2024) Past, present, and future of cell replacement therapy for parkinson\u2019s disease: a novel emphasis on host immune responses. Cell Res 34(7):479\u2013492","journal-title":"Cell Res"},{"issue":"9","key":"13101_CR106","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1242\/dmm.026294","volume":"10","author":"VM Pozo Devoto","year":"2017","unstructured":"Pozo Devoto VM, Falzone TL (2017) Mitochondrial dynamics in Parkinson\u2019s disease: a role for \u03b1-synuclein? Dis Model Mech. 10(9):1075\u20131087","journal-title":"Dis Model Mech."},{"issue":"2","key":"13101_CR107","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/febs.13820","volume":"284","author":"C Ploumi","year":"2017","unstructured":"Ploumi C, Daskalaki I, Tavernarakis N (2017) Mitochondrial biogenesis and clearance: a balancing act. Febs j 284(2):183\u2013195","journal-title":"Febs j"},{"key":"13101_CR108","doi-asserted-by":"publisher","first-page":"6727421","DOI":"10.1155\/2018\/6727421","volume":"2018","author":"SH Yun","year":"2018","unstructured":"Yun SH, Han SH, Park JI (2018) Peroxisome proliferator-activated receptor \u03b3 and PGC-1\u03b1 in cancer: dual actions as tumor promoter and suppressor. PPAR Res 2018:6727421","journal-title":"PPAR Res"},{"issue":"7","key":"13101_CR109","doi-asserted-by":"publisher","first-page":"e14852","DOI":"10.1111\/cns.14852","volume":"30","author":"B Xiong","year":"2024","unstructured":"Xiong B, Yang C, Yang X (2024) Correction to [Arctigenin derivative A-1 ameliorates motor dysfunction and pathological manifestations in SOD1(G93A) transgenic mice via the AMPK\/SIRT1\/PGC-1\u03b1 and AMPK\/SIRT1\/IL-1\u03b2\/NF-\u03baB pathways]. CNS Neurosci Ther. 30(7):e14852","journal-title":"CNS Neurosci Ther."},{"issue":"5","key":"13101_CR110","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.7150\/thno.70756","volume":"12","author":"L Yang","year":"2022","unstructured":"Yang L et al (2022) Non-invasive photobiomodulation treatment in an Alzheimer disease-like transgenic rat model. Theranostics 12(5):2205\u20132231","journal-title":"Theranostics"},{"key":"13101_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.646121","volume":"12","author":"LZ Qiu","year":"2021","unstructured":"Qiu LZ et al (2021) Repeated aconitine treatment induced the remodeling of mitochondrial function via AMPK-OPA1-ATP5A1 pathway. Front Pharmacol 12:646121","journal-title":"Front Pharmacol"},{"issue":"13","key":"13101_CR112","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.3390\/ijms25137059","volume":"25","author":"M Ciuro","year":"2024","unstructured":"Ciuro M et al (2024) Mitigating the functional deficit after neurotoxic motoneuronal loss by an inhibitor of mitochondrial fission. Int J Mol Sci 25(13):7059","journal-title":"Int J Mol Sci"},{"issue":"10","key":"13101_CR113","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15(10):565\u2013581","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"13101_CR114","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1038\/s41418-021-00766-3","volume":"28","author":"A Di Rita","year":"2021","unstructured":"Di Rita A et al (2021) Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy. Cell Death Differ 28(8):2499\u20132516","journal-title":"Cell Death Differ"},{"key":"13101_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176743","volume":"977","author":"L Li","year":"2024","unstructured":"Li L et al (2024) Cytarabine prevents neuronal damage by enhancing AMPK to stimulate PINK1\/Parkin-involved mitophagy in Parkinson\u2019s disease model. Eur J Pharmacol 977:176743","journal-title":"Eur J Pharmacol"},{"key":"13101_CR116","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jconrel.2022.06.022","volume":"348","author":"H Tian","year":"2022","unstructured":"Tian H et al (2022) A targeted nanomodulator capable of manipulating tumor microenvironment against metastasis. J Control Release 348:590\u2013600","journal-title":"J Control Release"},{"key":"13101_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2024.111961","volume":"221","author":"UR Bhandari","year":"2024","unstructured":"Bhandari UR et al (2024) New opportunities for antioxidants in amelioration of neurodegenerative diseases. Mech Ageing Dev 221:111961","journal-title":"Mech Ageing Dev"},{"key":"13101_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.636506","volume":"9","author":"V Nicoletti","year":"2021","unstructured":"Nicoletti V et al (2021) Understanding the multiple role of mitochondria in Parkinson\u2019s disease and related disorders: lesson from genetics and protein-interaction network. Front Cell Dev Biol 9:636506","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"13101_CR119","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.3390\/ijms25126622","volume":"25","author":"L Millichap","year":"2024","unstructured":"Millichap L et al (2024) The effect of neuronal CoQ(10) deficiency and mitochondrial dysfunction on a rotenone-induced neuronal cell model of Parkinson\u2019s disease. Int J Mol Sci 25(12):6622","journal-title":"Int J Mol Sci"},{"issue":"7\u20138","key":"13101_CR120","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3109\/21678421.2014.959024","volume":"15","author":"K Abe","year":"2014","unstructured":"Abe K et al (2014) Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 15(7\u20138):610\u2013617","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"39","key":"13101_CR121","doi-asserted-by":"publisher","first-page":"46406","DOI":"10.1021\/acsami.1c14818","volume":"13","author":"C Li","year":"2021","unstructured":"Li C et al (2021) Oral administration of resveratrol-selenium-peptide nanocomposites alleviates Alzheimer\u2019s disease-like pathogenesis by inhibiting A\u03b2 aggregation and regulating gut microbiota. ACS Appl Mater Interfaces 13(39):46406\u201346420","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"13101_CR122","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","volume":"34","author":"B Brakedal","year":"2022","unstructured":"Brakedal B et al (2022) The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease. Cell Metab 34(3):396-407.e6","journal-title":"Cell Metab"},{"issue":"10284","key":"13101_CR123","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P et al (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590","journal-title":"Lancet"},{"issue":"9","key":"13101_CR124","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.3390\/cells9092045","volume":"9","author":"E Zampese","year":"2020","unstructured":"Zampese E, Surmeier DJ (2020) Calcium, bioenergetics, and Parkinson\u2019s disease. Cells 9(9):2045","journal-title":"Cells"},{"issue":"5","key":"13101_CR125","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.stemcr.2018.09.006","volume":"11","author":"Y Tabata","year":"2018","unstructured":"Tabata Y et al (2018) T-type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in familial Parkinson disease. Stem Cell Reports 11(5):1171\u20131184","journal-title":"Stem Cell Reports"},{"issue":"17","key":"13101_CR126","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1111\/bph.14757","volume":"176","author":"E Heikkil\u00e4","year":"2019","unstructured":"Heikkil\u00e4 E et al (2019) The plant product quinic acid activates Ca(2+) -dependent mitochondrial function and promotes insulin secretion from pancreatic beta cells. Br J Pharmacol 176(17):3250\u20133263","journal-title":"Br J Pharmacol"},{"issue":"2","key":"13101_CR127","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1161\/CIRCULATIONAHA.120.052788","volume":"144","author":"S Geisberger","year":"2021","unstructured":"Geisberger S et al (2021) Salt transiently inhibits mitochondrial energetics in mononuclear phagocytes. Circulation 144(2):144\u2013158","journal-title":"Circulation"},{"issue":"1","key":"13101_CR128","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/nu8010027","volume":"8","author":"X Yu","year":"2016","unstructured":"Yu X et al (2016) Quercetin attenuates chronic ethanol-induced hepatic mitochondrial damage through enhanced mitophagy. Nutrients 8(1):27","journal-title":"Nutrients"},{"issue":"10","key":"13101_CR129","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3390\/ijms20102451","volume":"20","author":"M Naoi","year":"2019","unstructured":"Naoi M et al (2019) Mitochondria in neuroprotection by phytochemicals: bioactive polyphenols modulate mitochondrial apoptosis system, function and structure. Int J Mol Sci 20(10):2451","journal-title":"Int J Mol Sci"},{"issue":"2","key":"13101_CR130","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.apsb.2021.11.003","volume":"12","author":"E Trushina","year":"2022","unstructured":"Trushina E, Trushin S, Hasan MF (2022) Mitochondrial complex I as a therapeutic target for Alzheimer\u2019s disease. Acta Pharm Sin B 12(2):483\u2013495","journal-title":"Acta Pharm Sin B"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13101-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13101-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13101-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T13:04:14Z","timestamp":1747659854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13101-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":130,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["13101"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13101-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"364"}}